STOCK TITAN

CareDx to Report Fourth Quarter and Full Year 2021 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

CareDx, Inc. (Nasdaq: CDNA) announced it will release its financial results for Q4 and the full year 2021 on February 24, 2022, after market close. A conference call will follow at 1:30 PM PT / 4:30 PM ET. Interested participants can listen by calling 855-327-6837 in the U.S. or 631-891-4304 internationally, referencing Conference ID: 1001789, or via a live webcast on their investor relations website.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced it will report financial results for the fourth quarter and full year 2021 after market close on Thursday, February 24, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 855-327-6837 for domestic callers or 631-891-4304 for international callers. Please reference Conference ID: 1001789. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx – The Transplant Company
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
CareDx, Inc.
Investor Relations
Ian Cooney
415-287-2300 x 3550
investor@caredx.com 


FAQ

When will CareDx report its financial results for 2021?

CareDx will report its financial results for the fourth quarter and full year 2021 after market close on February 24, 2022.

How can I listen to the CareDx conference call?

You can listen to the CareDx conference call by calling 855-327-6837 for domestic calls or 631-891-4304 for international calls, referencing Conference ID: 1001789, or by visiting their investor relations website for a live webcast.

What time does the CareDx conference call start?

The CareDx conference call will begin at 1:30 PM Pacific Time / 4:30 PM Eastern Time on February 24, 2022.

What is CareDx's stock symbol?

CareDx's stock symbol is CDNA.

CareDx, Inc.

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Stock Data

1.22B
51.79M
3.44%
96.1%
6.43%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
BRISBANE